[go: up one dir, main page]

GR1008129B - Improved pharmaceutical composition containing an aldosterone antagonist and method for the preparation thereof - Google Patents

Improved pharmaceutical composition containing an aldosterone antagonist and method for the preparation thereof

Info

Publication number
GR1008129B
GR1008129B GR20130100009A GR20130100009A GR1008129B GR 1008129 B GR1008129 B GR 1008129B GR 20130100009 A GR20130100009 A GR 20130100009A GR 20130100009 A GR20130100009 A GR 20130100009A GR 1008129 B GR1008129 B GR 1008129B
Authority
GR
Greece
Prior art keywords
preparation
pharmaceutical composition
composition containing
aldosterone antagonist
improved pharmaceutical
Prior art date
Application number
GR20130100009A
Other languages
Greek (el)
Inventor
Ευαγγελος Ανδρεα Καραβας
Original Assignee
"Φαρματεν Α.Β.Ε.Ε.",
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by "Φαρματεν Α.Β.Ε.Ε.", filed Critical "Φαρματεν Α.Β.Ε.Ε.",
Priority to GR20130100009A priority Critical patent/GR1008129B/en
Publication of GR1008129B publication Critical patent/GR1008129B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • A61K31/585—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin containing lactone rings, e.g. oxandrolone, bufalin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to an improved pharmaceutical composition for oral administration comprising a therapeutically effective amount of an aldosterone antagonist which is in micronized form, wherein the composition is free of a wetting agent. It also relates to a process for the preparation thereof.
GR20130100009A 2013-01-08 2013-01-08 Improved pharmaceutical composition containing an aldosterone antagonist and method for the preparation thereof GR1008129B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GR20130100009A GR1008129B (en) 2013-01-08 2013-01-08 Improved pharmaceutical composition containing an aldosterone antagonist and method for the preparation thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GR20130100009A GR1008129B (en) 2013-01-08 2013-01-08 Improved pharmaceutical composition containing an aldosterone antagonist and method for the preparation thereof

Publications (1)

Publication Number Publication Date
GR1008129B true GR1008129B (en) 2014-03-06

Family

ID=50483665

Family Applications (1)

Application Number Title Priority Date Filing Date
GR20130100009A GR1008129B (en) 2013-01-08 2013-01-08 Improved pharmaceutical composition containing an aldosterone antagonist and method for the preparation thereof

Country Status (1)

Country Link
GR (1) GR1008129B (en)

Similar Documents

Publication Publication Date Title
MX2021011906A (en) Delayed release compositions of linaclotide.
PH12016501830A1 (en) Inhibitors of c5a for the treatment of viral pneumonia
JO3784B1 (en) Combined use of anti pd-1 and anti m-csf antibodies in the treatment of cancer
IN2013MU03583A (en)
MX2016004741A (en) Pharmaceutical composition comprising a trpa1 antagonist and an analgesic agent.
WO2014203275A3 (en) An improved process for the preparation of apixaban and intermediates thereof
MD20170048A2 (en) Abiraterone acetate formulation and methods of use
IN2014MN02236A (en)
MX2014010433A (en) Novel crystalline form of sitagliptin sulfate.
IN2013MU03641A (en)
PH12017500089B1 (en) Aldosterone synthase inhibitors
UA117154C2 (en) S1p3 antagonists
MX366829B (en) Itraconazole compositions and dosage forms, and methods of using the same.
MX2015010486A (en) Chewable composition for oral administration and process for preparing thereof.
IL236562A0 (en) Pharmaceutical composition having improved flowability, medicinal agent, and method for producing and using same
GR1008129B (en) Improved pharmaceutical composition containing an aldosterone antagonist and method for the preparation thereof
IN2013CH04314A (en)
IN2013MU03428A (en)
IN2013MU03123A (en)
IN2013MU02059A (en)
IN2013MU02366A (en)
WO2014141298A3 (en) Stable pharmaceutical composition of fingolimod
IN2013CH05440A (en)
IN2013MU02279A (en)
IN2013MU03639A (en)

Legal Events

Date Code Title Description
PG Patent granted

Effective date: 20140416